254
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Different Smoking Statuses on Survival and Emphysema in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 505-515 | Published online: 05 Mar 2022

References

  • Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep. 2013;61(4):1–117
  • GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390(10100):1151–1210. doi:10.1016/S0140-6736(17)32152-9
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557-582. doi:10.1164/rccm.201701-0218PP
  • Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–191. doi:10.7326/0003-4819-155-3-201108020-00008
  • Labaki WW, Han MK. Improving detection of early chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2018;15(Supplement_4):S243–S248. doi:10.1513/AnnalsATS.201808-529MG
  • Yan Y, Yi N, Mengwu T, et al. Major finding of 2015 China adults tobacco survery. Chin J Health Manage. 2016;10(2):85–87. doi:10.3760/cma.j.issn.1674-0815.2016.02.002
  • Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health CPH study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
  • Chronic Obstructive Pulmonary Disease Group of Chinese Thoracic S, Chronic Obstructive Pulmonary Disease Committee of Chinese Association of Chest P. Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021). Chin J Tuberc Respir Dis. 2021;44(3):170–205. doi:10.3760/cma.j.cn112147-20210109-00031
  • Maselli DJ, Bhatt SP, Anzueto A, et al. Clinical epidemiology of COPD. Chest. 2019;156(2):228–238. doi:10.1016/j.chest.2019.04.135
  • Wei X, Yu N, Ding Q, et al. The features of AECOPD with carbon dioxide retention. BMC Pulm Med. 2018;18(1):124. doi:10.1186/s12890-018-0691-8
  • Wei X, Ding Q, Yu N, et al. Imaging features of chronic bronchitis with Preserved Ratio and Impaired Spirometry (PRISm). Lung. 2018;196(6):649–658. doi:10.1007/s00408-018-0162-2
  • Wei X, Shi Z, Cui Y, et al. Impulse oscillometry system as an alternative diagnostic method for chronic obstructive pulmonary disease. Medicine. 2017;96(46):e8543. doi:10.1097/MD.0000000000008543
  • Wei X, Ma Z, Yu N, et al. Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:121–129. doi:10.2147/COPD.S152826
  • Yu N, Wei X, Li Y,et al. Computed tomography quantification of pulmonary vessels in chronic obstructive pulmonary disease as identified by 3D automated approach. Medicine. 2016;95(40):e5095. doi:10.1097/MD.0000000000005095
  • Bourbeau J, Tan WC, Benedetti A, et al. Canadian Cohort Obstructive Lung Disease (CanCOLD): fulfilling the need for longitudinal observational studies in COPD. COPD. 2014;11(2):125–132. doi:10.3109/15412555.2012.665520
  • Tan WC, Sin DD, Bourbeau J, et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015;70(9):822–829. doi:10.1136/thoraxjnl-2015-206938
  • Salvi SS, Brashier BB, Londhe J, et al. Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease. Respir Res. 2020;21(1). doi:10.1186/s12931-020-1310-9
  • Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–743. doi:10.1016/S0140-6736(09)61303-9
  • Han MK, Kazerooni EA, Lynch DA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011;261(1):274–282. doi:10.1148/radiol.11110173
  • Mohamed Hoesein FA, de Hoop B, Zanen P, et al. CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax. 2011;66(9):782–787. doi:10.1136/thx.2010.145995
  • Xie M, Wang W, Dou S,et al. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:953–961. doi:10.2147/COPD.S104484
  • Corlăţeanu A, Odajiu I, Botnaru V,et al. From smoking to COPD–current approaches. Pneumologia. 2016;65(1):20–23.
  • Silverman EK, Vestbo J, Agusti A, et al. Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD. 2011;8(2):121–135. doi:10.3109/15412555.2011.558864
  • Charbonnier JP, Pompe E, Moore C, et al. Airway wall thickening on CT: relation to smoking status and severity of COPD. Respir Med. 2019;146:36–41.doi:10.1016/j.rmed.2018.11.014
  • James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J. 2007;30(1):134–155. doi:10.1183/09031936.00146905